The Patent Finder

Zynerba Pharmaceuticals, Inc.

16 patents currently held · Updated Nov 15, 2026
4 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.

Recorded as renamed to Harmony Biosciences Management, Inc. (2024)

7
Ending by 2030
Sep 2027
Next term end

When these terms end

Held patents by the year their term ends
20262027202820292030203120322033203420352036203720382039204020412042204320442045

Fee deadlines

Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
  • 1 fee due Dec 11, 2026
    The maintenance fee for Treatment of Autism with Cannabidiol (US 10,314,792) comes due Dec 11, 2026. Unpaid by Jun 11, 2027, it lapses early.
  • 1 fee due Apr 10, 2027
    The maintenance fee for Treatment of Fragile X Syndrome with Cannabidiol (US 11,779,549) comes due Apr 10, 2027. Unpaid by Oct 12, 2027, it lapses early.
  • 1 fee due May 12, 2027
    The maintenance fee for Treatment of Fragile X Syndrome with Cannabidiol (US 10,471,022) comes due May 12, 2027. Unpaid by Nov 12, 2027, it lapses early.
  • 1 fee due Aug 25, 2027
    The maintenance fee for Treatment of Autism with Cannabidiol (US 10,568,848) comes due Aug 25, 2027. Unpaid by Feb 25, 2028, it lapses early.

Which patents, and when each one lapses · Pro

Recent changes

Nothing was recorded against this company's patents in the last 90 days.

Patents held now

Soonest term end first. Each date below is computed on that patent's own page, which shows the rule, the adjustments and the fee history it was derived from.
PatentTitleStatus Expires Confidence
US 7,511,054Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
In force
 · High confidence
In forceHigh confidence
US 8,309,568Transdermally Deliverable Opioid Prodrugs, Abuse-Resistant Compositions and Methods of Using Opioid Prodrugs
In force
 · High confidence
In forceHigh confidence
US 9,695,143Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
In force
 · High confidence
In forceHigh confidence
US 9,957,246Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
In force
 · High confidence
In forceHigh confidence
US 8,980,942Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
In force (reinstated)
 · High confidence
In force (reinstated)High confidence
US RE47,885Use of Cannabidiol Prodrugs in Pharmaceutical Compositions
In force
 · Low confidence
In forceLow confidence
US 8,293,786Prodrugs of Cannabidiol, Compositions Comprising Prodrugs of Cannabidiol and Methods of Using the Same
In force
 · High confidence
In forceHigh confidence
US 8,227,627Prodrugs of Tetrahydrocannabinol, Compositions Comprising Prodrugs of Tetrahydrocannabinol and Methods of Using the Same
In force
 · High confidence
In forceHigh confidence
US 10,213,390Treatment of Fragile X Syndrome with Cannabidiol
In force
 · High confidence
In forceHigh confidence
US 10,314,792Treatment of Autism with Cannabidiol
In force
 · High confidence
In forceHigh confidence
10 of 16 patents shown.
Pro members see all 16.
Pro members: see all 16 patents
Also on record, not counted in the 16: 4 patents in force now held by others · 1 lapsed for an unpaid fee · 2 ended at full term · 1 surrendered on reissue. List them

Sources and methods

Compiled from the USPTO record, grants, published applications and recorded assignments, not yet reviewed by hand. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.

Published applications

US patent applications published under this name that have not become patents. An application is published about eighteen months after its earliest filing; one that has not been published is in no public record.

3 pending · 22 abandoned · 1 no status recorded

List them

The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited